Jun N-terminal kinases or JNKs play a critical role in death receptor-initiated extrinsic as well as mitochondrial intrinsic apoptotic pathways. JNKs activate apoptotic signaling by the upregulation of pro-apoptotic genes through the transactivation of specific transcription factors or by directly modulating the activities of mitochondrial pro-and antiapoptotic proteins through distinct phosphorylation events. This review analyses our present understanding of the role of JNK in apoptotic signaling and the various mechanisms by which JNK promotes apoptosis.
Introduction
Jun N-terminal kinases (JNKs) belong to the superfamily of MAP kinases that are involved in the regulation of cell proliferation, differentiation and apoptosis. Analyses of pathways regulated by JNKs have shown that JNKs are indispensable for both cell proliferation and apoptosis. Whether the activation of JNKs leads to cell proliferation or apoptosis is dependent on the stimuli and the cell type involved in such activations (Lin and Dibling, 2002; Liu and Lin, 2005) . The JNK family of MAP kinases was initially identified as ultraviolet (UV)-responsive protein kinases involved in the transactivation of c-Jun by phosphorylating the N-terminal Ser63 and Ser73 residues (Hibi et al., 1993; De´rijard et al., 1994) . Although initial studies have shown that JNKs can be activated by several different stimuli including growth factors (Hibi et al., 1993; Davis, 1994; Prasad et al., 1995) , cytokines (Westwick et al., 1994) and stress factors (Cano et al., 1994) , the observations that inflammatory cytokines and many different cytotoxic as well as genotoxic agents stimulate JNKs unraveled the critical role of JNKs in mediating apoptotic signaling (Sluss et al., 1994; Cano and Mahadevan, 1995; Dai et al., 1995) .
Signaling pathways that initiate apoptosis have been broadly classified into (1) extrinsic pathways initiated by death receptors such as those of tumor necrosis factor (TNF)-a, TRAIL and FAS-L, and (2) intrinsic pathways initiated by mitochondrial events (Elmore, 2007) . JNK has been observed to have a central role in both of these pathways. To date, multiple splice variants of JNKs encoded by three distinct genes, namely JNK1, JNK2 and JNK3, have been identified (Davis, 2000; Johnson and Nakamura, 2007) . JNKs form the last tier of the three-tier kinase module consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAP2K) and MAP kinase (MAPK) (Dhanasekaran and Reddy, 1998; (Figure 1 ). In response to specific stimuli, the penultimate dualspecificity kinase of the tier, either MKK4 or MKK7, activates JNKs by phosphorylating the Thr and Tyr residues of the TXY motif within the activation loop of the respective JNKs (Dhanasekaran and Reddy, 1998) . While MKK4 can activate both p38MAPK and JNK, MKK7 is specifically involved in the activation of JNKs. Both antiapoptotic and pro-apoptotic signals converge on activating MKK4-JNK or MKK7-JNK signaling nodes through specific MAP3Ks. JNKs in turn activate apoptotic signaling either through the upregulation proapoptotic genes through the transactivation of specific transcription factors such as c-Jun or by directly modulating the activities of mitochondrial pro-and antiapoptotic proteins through phosphorylation events. Although the apoptotic stimuli can also involve the stimulation of p38MAPK, this review specifically analyses our current understanding of the mechanisms through which JNK-signaling module is involved in mediating apoptosis.
Role of MAP3Ks in coupling stress stimuli to JNK
Of the 20 MAP3Ks that have been identified, 14 have been observed to be involved in the activation of JNKs through MKK4 or MKK7 (Fanger et al., 1997; Johnson and Nakamura, 2007; Raman et al., 2007) (Figure 1) . MEKK1 was the first member to be identified to be involved in promoting apoptosis through the JNK signaling pathway (Widmann et al., 1998) . Subsequent studies have shown that all of the MAP3Ks that can activate MKK4 or MMK7 can initiate JNK-mediated apoptotic pathways in a cell type-and stimuli-specific manner. It has been observed that the MLK family of kinases including MLK1, MLK2, MLK3 and DLK are involved in transmitting signals from Rac/CDC42 to MKK4/7-JNK to induce neuronal cell apoptosis in response to the deprivation of nerve growth factor (Xu et al., 2001) . It has also been observed that DLKmediated activation of JNK is required for calphostin c-induced apoptosis of a breast cancer cell line (Robitaille et al., 2008) . Similarly, Zak-activated JNK has been shown to be involved in the apoptosis of hepatoma cell lines (Liu et al., 2000a) . Of these different MAP3Ks that link JNK-mediated apoptotic pathways to upstream stress stimuli, the mechanism by which apoptosis signalregulating kinase 1 (ASK1) links diverse apoptotic stimuli to JNK is well characterized (Matsuzawa and Ichijo, 2001; Nagai et al., 2007) . ASK1 is activated by diverse apoptotic stimuli such as TNF-a, reactive oxygen species, lipopolysaccharide and endoplasmic reticulum stress (Figure 2) . During TNF-a-mediated apoptotic signaling, it appears that reactive oxygen species-dependent activation of ASK1 by TNF receptorassociated factor 2 (TRAF2) leads to the subsequent stimulation of JNK module and apoptosis (Matsuzawa and Ichijo, 2001; Nagai et al., 2007) . Similar mechanism involving TRAF2 has been proposed for the activation of ASK1-MKK-JNK-mediated apoptotic signaling. In the case of lipopolysaccharide, TRAF6, which is closely related to TRAF2, has been shown to link lipopolysaccharide stimuli to the activation of ASK1 (Nagai et al., 2007) . Oxidative stress has been shown to recruit both TRAF2 and TRAF6 to activate ASK1 and downstream JNK signaling (Liu et al., 2000a, b; Fujino et al., 2007) . Although studies with ASK À/À embryonic fibroblasts have indicated that ASK1 is not required for the transient activation of JNK, it is required for the persistent activation of JNK and apoptosis induced by TNF-a (Tobiume et al., 2001) . Similar activation of ASK1 and the subsequent stimulation of JNK has been implicated in cisplatin-induced apoptosis of ovarian carcinoma cells (Chen et al., 1999) .
Role of JNKs in apoptotic signaling
All three JNKs have been shown to be involved in stimulating apoptotic signaling. The primary evidence that the activation of JNK-1 can be correlated with apoptosis came from the initial studies investigating g-ray-induced apoptosis (Chen et al., 1996) . These studies have indicated that g-rays stimulate a rather delayed but persistent activation of JNK-1 in Jurkat cells with a concomitant increase in DNA fragmentation. Although these initial studies failed to establish a cause-and-effect relationship between JNK and DNA fragmentation, the results indicated an underlying difference between the growth factor induced, presumably antiapoptotic JNK activation versus g-ray-induced pro-apoptotic activation. g-Ray-induced JNK activation was delayed, similar to UV-induced JNK activation; however, the growth factor-induced JNK activation was rapid and transient. Subsequent studies have clearly established the role of JNK in TNF-a-, Fas ligand-, X-ray-and UV ray-induced apoptosis (Verheij et al., 1996; Wilson et al., 1996; Zanke et al., 1996) .
Unequivocal evidence that JNK1 and JNK2 are involved in apoptotic signaling came from studies using embryonic fibroblasts derived from JNK1 (Tournier et al., 2000) . These JNK À/À mouse embryonic fibroblasts (MEFs) showed resistance to apoptosis in response to UV irradiation, DNA-alkylating agent methyl methanesulfate and translation inhibitor anisomycin. The defect in apoptosis can be correlated with the lack of mitochondrial depolarization, cytochrome c release and the activation of caspases. Interestingly, these cells were responsive to Fas-mediated apoptosis, suggesting that JNK1 and JNK2 are not required for Fas-induced apoptosis of these fibroblasts. It has also been observed that MEFs carrying non-phosphorylatable alanine mutations in c-Jun showed similar resistance to UV-induced apoptosis (Behrens et al., 1999) . Together, these studies suggest that JNK1 and JNK2 and their phosphorylation of c-Jun are required for UV-induced apoptosis. The role of JNK3 in apoptosis was also established using JNK3 À/À mice (Yang et al., 1997) . It is known that the excitotoxic agents, such as kainite and glutamate, induce apoptosis of the hippocampal neurons in wild-type mice. In striking contrast, JNK3 À/À mice were observed to be quite resistant to glutamate-induced apoptosis of their hippocampal neurons. Interestingly, MEFs from JNK À/À
JNK2
À/À mice did not show such resistance to excitotoxic apoptosis. In contrast, MEFs from mice carrying non-phosphorylatable alanine mutations at Ser63 and Ser73 exhibited resistance to excitotoxic apoptosis similar to that seen with JNK3 deficiency, thereby suggesting the critical role of JNK3 and its phosphorylation of c-Jun in excitotoxic cell death. In addition to these direct lines of evidence that have established a role for JNKs in pro-apoptotic signaling, studies using JNK-specific inhibitors have also corroborated the proapoptotic role of JNKs. JNK-specific inhibitors have been shown to attenuate the apoptosis of hepatocytes and sinusoidal endothelial cells during hepatic I/R injury (Uehara et al., 2005) . Likewise, a JNK inhibitor has been shown to inhibit the apoptosis of cardiomyocytes using a rat cardiac I/R animal model (Ferrandi et al., 2004) . Although the pro-apoptotic role of JNKs is beginning to be understood, it should be noted here that the pro-apoptotic role of JNK is often determined by other cellular factors. These may include the parallel activation of cell survival or antiapoptotic pathway and the overall apoptotic signaling strength. It appears that the sustained activation of JNK is associated with apoptosis, whereas the acute and transient activation of JNK is involved in cell proliferative or survival pathway (Sa´nchez-Perez et al., 1998: Chen and Tan, 2000) .
Nuclear signaling of JNK in the regulation of apoptosis
Upon activation by the upstream MAP2Ks, the phosphorylated JNK translocates to the nucleus where it phosphorylates and transactivates c-Jun (Davis, 2000; Chang and Karin, 2001 ). Phosphorylation of c-Jun leads to the formation of activator protein 1 (AP-1), which is involved in the transcription of a wide variety of proteins, some of them being the known proapoptotic factors (Dhanasekaran and Johnson, 2007; Raman et al., 2007; Turjanski et al., 2007) . It has been noted that the JNK-AP-1 pathway is involved in the increased expression of pro-apoptotic genes such as TNF-a, Fas-L and Bak (Fan and Chambers, 2001) . JNK can also phosphorylate several other transcription factors including JunD, ATF2, ATF3, Elk-1, Elk-3, p53, RXRa, RARb, AR, NFAT4, HSF-1 and c-Myc (Johnson and Nakamura, 2007) . Thus, in the context of apoptosis, the nuclear activity of JNK can potentially In pathways directed at mitochondrial apoptotic proteins, activated JNK translocates to mitochondria. There, JNK can phosphorylate the BH3-only family of Bcl2 proteins to antagonize the antiapoptotic activity of Bcl2 or Bcl-X L . In addition, JNK can stimulate the release of cytochrome c (Cyt C) from the mitochondrial inner membrane through a Bid-Bax-dependent mechanism, promoting the formation of apoptosomes consisting of cytochrome c, caspase-9 (Casp 9) and Apaf-1. This complex initiates the activation of caspase-9-dependent caspase cascade. In another mechanism, JNK can promote the release of Smac/Diablo (Smac) that can inhibit the TRAF2/IAP1 inhibitory complex, thereby relieving the inhibition on caspase-8 to initiate caspase activation. In addition, by phosphorylating BAD and its sequestering partner 14-3-3, JNK can promote BAD-mediated neutralization of the Bcl2 family of antiapoptotic proteins. Finally, JNK can phosphorylate Bcl2 for suppressing its antiapoptotic activity (see text for details). These nuclear and mitochondrial events regulated by JNK need not be mutually exclusive. JNK, Jun N-terminal kinase; TRAF2, TNF-receptor-associated factor 2.
lead to an increase in the expression of pro-apoptotic genes and/or a decrease in the expression of pro-survival genes ( Figure 2 ). There is sufficient evidence that the nuclear activity of JNK such as its translocation to the nucleus and the transactivation of c-Jun are required for its apoptotic activity. It has been observed that JNK is required for the apoptosis of central nervous system neurons, and the expression of dominant-negative inhibitors of nuclear JNK confer resistance to their apoptosis following trophic support withdrawal (Bjo¨rkblom et al., 2008) . These findings indicate an important role for nuclear JNK in promoting apoptotic signaling. It is significant to note here that the nonphosphorylatable mutants of c-Jun confer resistance to apoptosis of MEFs in response to UV irradiation (Behrens et al., 1999) . Together, these results are indicative of a role for JNK-c-Jun/Ap1-mediated expression of pro-apoptotic genes in JNK-mediated apoptosis. However, this may not be a universal mechanism. It has been noted that the silencing of c-Jun and ATF2 using small interfering RNA does not protect the central nervous system neurons against apoptosis in response to trophic hormone withdrawal (Bjo¨rkblom et al., 2008) , suggesting that these transcription factors may not have a role in the apoptosis of at least central nervous system neurons. In contrast, the apoptosis of hippocampal neurons, cerebellar granule neurons (Mei et al., 2008) or developing neurons (Barone et al., 2008) appears to require a mechanism involving the activation of c-Jun by JNK. Thus, whether JNK activation of c-Jun is required for apoptotic signaling appears to be very much dependent on the cell type in which JNK is activated. In addition, the type of apoptotic stimuli plays a greater role in defining whether JNK-activated c-Jun is required for apoptosis. This is significantly exemplified in JNK-dependent apoptosis induced by two distinct microtubule inhibitors, vinblastine and taxol, in breast cancer cells (Kolomeichuk et al., 2008) . Both vinblastine and taxol induce mitotic arrest and subsequent apoptotic cell death with similar kinetics. Although both drugs activate JNK and induce c-Jun expression, only vinblastine induces c-Jun phosphorylation and c-jun transcriptional activation. However, the inhibition of JNK or knockdown of JNK conferred resistance to both vinblastine-and taxol-induced apoptosis. Thus, these results strongly suggest that although JNK activation has a critical role in apoptosis induced by both vinblastine and taxol, the requirement for c-Jun/AP-1 activation differs according to the apoptotic stimuli. Considering the possibility that JNK can phosphorylate and transactivate other transcription factors, it is likely that c-Jun is not the only obligatory substrate in all the cellular or physiological contexts pertaining to apoptosis.
An alternate pathway contributing to JNK-mediated apoptosis involves the phosphorylation of p53 family of proteins by JNK (Fuchs et al., 1998) . It has been suggested that the phosphorylation of p53 at Ser6 by JNK inhibits ubiquitin-mediated degradation of p53, thereby stabilizing the levels of p53. Recent studies have shown that the phosphorylation of p53 at Ser6 by JNK2 is critically required for the apoptotic pathway (Oleinik et al., 2007) . It has been observed that the expression of 10-formyltetrahydrofolate dehydrogenase is drastically reduced in tumors and that its elevation induces p53-dependent apoptosis. Further analyses of this apoptotic event indicated that 10-formyltetrahydrofolate dehydrogenase induces direct phosphorylation of p53 at Ser6 involving both JNK1 and JNK2. Treatment of 10-formyltetrahydrofolate dehydrogenase-expressing cells with JNK inhibitor SP600125 or silencing of JNK1/2 inhibited the phosphorylation of p53 at Ser6 as well as p53-dependent apoptosis in response to DNA damage. As p53 is involved in the expression of several pro-apoptotic genes such as Bax (Bcl2-associated X protein) and PUMA (p53-upregulated modulator of apoptosis), it is quite possible that apoptotic pathways activated by JNK involve p53-mediated upregulation of pro-apoptotic genes.
DNA damage that activates JNK also causes the stabilization and activation of p73, a member of the p53 family of transcription factors (Jones et al., 2007) . Similar to p53, p73 induces apoptosis by increasing the expression of pro-apoptotic genes including Bax and PUMA. Analysis of this pathway has shown that JNK is required for p73-mediated apoptosis induced by the DNA-damaging agent cisplatin and that it involves the phosphorylation of p73 at several serine and threonine residues. Consistent with the notion that JNK and its activity are required for p73-mediated apoptosis, inhibition of JNK-mediated phosphorylation of p53 abrogates cisplatin-induced stabilization of p73 along with a marked reduction in p73 transcriptional activity and cisplatin-induced apoptosis. Thus, JNK can stimulate the expression of pro-apoptotic genes and decrease the expression pro-survival genes through multiple transcription factors in cell type-and stimuli-specific manner.
Mitochondrial signaling of JNK in the regulation of apoptosis
Diverse apoptotic signals such as DNA damage, oxidative stress, deprivation of growth factors and irradiation finally converge on mitochondria to release the apoptotic proteins from the inner membrane space. In addition to the canonical nuclear signaling that leads to the upregulation of pro-apoptotic and/or downregulation of antiapoptotic genes, JNKs have an essential role in modulating the functions of pro-and antiapoptotic proteins located in the mitochondria (Aoki et al., 2002; Schroeter et al., 2003) . Accordingly, following activation by apoptotic stimuli, JNK readily translocates to mitochondria (Kharbanda et al., 2000; Chauhan et al., 2003) . The crucial mitochondrial event initiating apoptosis is the release of cytochrome c from the inner membrane space of mitochondria. Released cytochrome c, in combination with Apaf-1 and caspase-9, form the apoptosomes, which activate the capase-9 cascade (Chinnaiyan, 1999; Hill et al., 2004) . JNK has been shown to be critically required for the release of cytochrome c from mitochondria during the UVinduced apoptosis of MEFs, as JNK1 À/À JNK2 À/À MEFs failed to show the release of cytochrome c in response to UV irradiation (Tournier et al., 2000) . Although the precise mechanism by which JNK mediates cytochrome c release in not fully understood, several lines of evidence indicate that JNK-induced cleavage of Bid, a pro-apoptotic BH3-only member of Bcl2 family of apoptotic proteins, has a role in this process (Madesh et al., 2002) . In the case of extrinsic apoptotic pathways initiated by death receptors, caspase-8-dependent cleavage of Bid and the resultant 15.5 kDa C-terminal fragment of Bid, known as tBid, translocates to mitochondria where it activates Bax. The activated Bax forms membrane channels through which apoptogenic proteins such as cytochrome c can be released (Bossy-Wetzel and Green, 1999; Kuwana et al., 2002; Madesh et al., 2002) . It is significant to note here that during TNF-a-induced apoptosis of HeLa cells, JNK has been shown to induce caspase-8-independent cleavage of Bid, and the resultant 21 kDa fragment of Bid (jBid) translocates to mitochondria and selectively promotes the release of the pro-apoptotic protein Smac/DIABLO (Deng et al., 2003) . Although the mechanism through which JNK induces the cleavage of Bid is still elusive, it is more likely that activated JNK stimulates the release of cytochrome c from mitochondria through an analogous pathway involving the proapoptotic proteins Bid and Bax. It is quite possible that a similar mechanism underlies the release of Smac/ DIABLO during stress-induced apoptosis of multiple myeloma cells (Chauhan et al., 2003) . It is worth noting here that the ability of JNK to induce Bid cleavage and thereby promote the release of Smac/DIABLO links it to another mechanism through which it can mediate apoptotic signaling. During apoptosis induced by TNF-a, JNK promotes the release of jBID as described above (Deng et al., 2003) . The released Smac/DIABLO has been proposed to disrupt the TRAF2-cIAP1 complex, which is involved in the inhibition of caspase-8 activation (Figure 2) . Thus JNK appears to have a critical role in the extrinsic pathway from mitochondrial events.
JNK has also been observed to modulate the activities of other pro-apoptotic BH3-only subgroup of Bcl2 family of proteins such as Bim and Bmf (Lei and Davis, 2003) . During UV-induced apoptosis of HEK293T cells, the phosphorylation of Bim and Bmf by JNK releases them from the hold of the sequestering dynein and myosin V motor complexes. Once they are released, the phosphorylated Bim and Bmf can activate Bax and/or Bak to initiate apoptosis (Letai et al., 2002; Lei et al., 2002; Marani et al., 2002) . Alternatively, phosphorylated Bim can bind and neutralize the antiapoptotic activities of Bcl2 and Bcl X L , thereby promoting apoptosis (Puthalakath et al., 1999; Puthalakath and Strasser, 2002) . Another BH3-only pro-apoptotic member of Bcl2 family targeted by JNK to promote apoptosis is Bad. JNK specifically phosphorylates the Ser128 of BAD and promotes the apoptotic effect of BAD in the primary granule neurons of the rat cerebellum (Donovan et al., 2002) . BAD promotes cell death by interacting with and inhibiting the pro-survival Bcl-2 proteins (Gross et al., 1999) . Normally, the prosurvival kinases such as Akt-1, PAK-1 and PKA inhibit the pro-apoptotic activity of BAD by phosphorylating it at serine 136, serine 112 or both. The Ser112/136-phosphorylated BAD is sequestered by 14-3-3 family of proteins (Gross et al., 1999) . Apparently, Ser128 phosphorylation of BAD inhibits its interaction with 14-3-3 proteins so that BAD can antagonize the antiapoptotic Bcl2 proteins to promote apoptosis (Wang et al., 2007) . JNK seems to further potentiate the pro-apoptotic role of BAD by phosphorylating 14-3-3z protein at Ser184 (Tsuruta et al., 2004) , following which 14-3-3 releases the sequestered BAD (Sunayama et al., 2005) . Thus, JNK appears to ensure the proapoptotic signaling by phosphorylating Ser128 of Bad and Ser184 of 14-3-3z.
In addition to stimulating the activities of proapoptotic proteins, especially those of BH3-only family of proteins, JNK promotes apoptosis by inhibiting the antiapoptotic proteins such as Bcl2. During microtubule-damaging agent-induced apoptosis of breast cancer cells, it has been shown that JNK is activated and the activated JNK is involved in the phosphorylation of Bcl2 at Ser70 (Srivastava et al., 1999; Yamamoto et al., 1999) . MKP-1-mediated dephosphorylation of phospho-JNK or the mutation of Ser70 to Ala inhibited paclitaxel-induced apoptosis of these cells. Together, these findings suggest that JNK phosphorylates Bcl2 to suppress its antiapoptotic activity.
Conclusion
An overview of apoptotic pathways indicates that JNK signaling is involved in the extrinsic apoptotic pathway initiated by death receptors as well as the intrinsic pathway initiated at the mitochondria. In response to both the extrinsic and intrinsic apoptotic stimuli, JNK plays an essential role through its ability to interact and modulate the activities of diverse pro-and antiapoptotic proteins. Through the coordinated regulation of the nuclear and mitochondrial events, JNK ensures the efficient execution of apoptosis. With the identification of primary apoptotic signaling nodes regulated by JNK, the finer details of JNK signaling in apoptosis, specifically in relation to other growth-stimulating stimuli, are finally emerging and this should unravel novel therapeutic targets for diverse pathological conditions such as Alzheimer's disease and cancer.
